Lineage Cell Therapeutics Inc

LCTX's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

LCTX Growth rates comparisons

Lineage Cell Therapeutics Inc 's sales fell by -2.59 % in the third quarter of 2025 from the same quarter a year ago. Ranking at No. 175

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 3.51 %

Lineage Cell Therapeutics Inc net loss increased from $-3 millions, to $-30 millions in third quarter of 2025,

• More on LCTX's Growth

LCTX's Valuation comparisons

Lineage Cell Therapeutics Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 31.43 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 36.82.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.

• More on LCTX's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	53,811
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	35.06
Tangible Book Value (Per Share $)	-0.09

LCTX's Valuation comparisons

Lineage Cell Therapeutics Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 31.43 in trailing twelve-month period.

Company

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 36.82.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.36.

Lineage Cell Therapeutics Inc Price to Book Ratio is at 19.15 lower than Industry Avg. of 1638.34. and higher than S&P 500 Avg. of 0.02

• More on LCTX's Valuation

• Market Capitalization (Millions $)	398
• Shares Outstanding (Millions)	229
• Employees	201
• Revenues (TTM) (Millions $)	11
• Net Income (TTM) (Millions $)	-68
• Cash Flow (TTM) (Millions $)	13
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	53,811
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	35.06
• Tangible Book Value (Per Share $)	-0.09

• Market Capitalization (Millions $)	398
• Shares Outstanding (Millions)	229
• Employees	201
• Revenues (TTM) (Millions $)	11
• Net Income (TTM) (Millions $)	-68
• Cash Flow (TTM) (Millions $)	13
• Capital Exp. (TTM) (Millions $)	0

	*Ratio*
• Capital Ratio (MRQ)	4.5
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.11
• Inventory Turnover Ratio (TTM)	-

LCTX's Profitability Comparisons

• More on LCTX's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.